ComplyRx

Immunology & inflammation · Live ClinicalTrials.gov data

Risankizumab (Skyrizi) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 risankizumab (Skyrizi) trials on ClinicalTrials.gov by enrolment, 5 of them actively recruiting. The next phase 3 primary completion among them is expected Mar 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

10

Phase 3 trials

5

Actively recruiting

Mar 2027

Next phase 3 primary completion

10,578

Participants across trials

AbbVie

Lead sponsor by trial count

risankizumab (16)7 active2016–2033
risankizumab
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingCompleted
'16
'18
'20
'22
'24
'26
'28
'30
'32
risankizumab
BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisP3
BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatmentP3
BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisP3
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisP2
FORTIFYP3
Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisP3
KEEPsAKE2P3
A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or IxekizumabP3
SOPRANO-CDP4
PATHFINDERP4
AFFIRMP3
IMMpactfulP4
Target CDP2
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic ArthritisP3
CHARGEP3
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisP2

Upcoming readouts

7 ahead · risankizumab

Select a trial to load its full ClinicalTrials.gov record.

Key risankizumab trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT05928039PATHFINDER: PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active…Phase 4RecruitingJul 2027
NCT05169593SOPRANO-CD: Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biolog…Phase 4RecruitingOct 2027
NCT06333860IMMpactful: A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Trea…Phase 4CompletedMar 2026
NCT07499232CHARGE: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro…Phase 3RecruitingNov 2028
NCT06063967AFFIRM: A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Ind…Phase 3Active, not recruitingMar 2027
NCT03105102FORTIFY: A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseasePhase 3Active, not recruitingFeb 2029
NCT02684357BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe C…Phase 3CompletedDec 2016
NCT02684370BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients Wit…Phase 3CompletedDec 2016
NCT02672852BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withd…Phase 3CompletedAug 2017
NCT03671148KEEPsAKE2: A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Includ…Phase 3CompletedJun 2020
NCT03478787Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisPhase 3CompletedJul 2020
NCT04102007A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis W…Phase 3CompletedJan 2022

Track risankizumab with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track risankizumab

Related drug pipelines

Compare risankizumab vs dupilumabCompare risankizumab vs lebrikizumab

FAQ

How many clinical trials are running for risankizumab?
ClinicalTrials.gov lists more than 16 phase 2–4 risankizumab trials. This page tracks the 16 largest by enrolment: 3 phase 2, 10 phase 3, and 3 phase 4 among them, with 5 actively recruiting. Updated daily.
Are there clinical trials for Skyrizi?
Skyrizi is the brand name for risankizumab, so risankizumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 risankizumab trials. This page tracks the 16 largest by enrolment: 3 phase 2, 10 phase 3, and 3 phase 4 among them, with 5 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare risankizumab against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.